Home/Filings/4/0001599901-25-000198
4//SEC Filing

McCarthy Teresa 4

Accession 0001599901-25-000198

CIK 0001599901other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:27 PM ET

Size

9.0 KB

Accession

0001599901-25-000198

Insider Transaction Report

Form 4
Period: 2025-10-15
McCarthy Teresa
Chief Human Resources Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-15$22.34/sh+20,000$446,800117,130 total
  • Sale

    Common Stock

    2025-10-15$50.15/sh20,000$1,003,05897,130 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-10-1520,00065,000 total
    Exercise: $22.34Exp: 2031-02-01Common Stock (20,000 underlying)
Footnotes (3)
  • [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on April 11, 2025.
  • [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $48.20 to $51.19. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The shares subject to this option award are fully vested and exercisable as of the date hereof.

Issuer

Avidity Biosciences, Inc.

CIK 0001599901

Entity typeother

Related Parties

1
  • filerCIK 0001862121

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:27 PM ET
Size
9.0 KB